Fundraising FoxMentari Therapeutics
1 known investors
Find your way into Mentari Therapeutics
Sign up to see every warm intro you have to Mentari Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Mentari Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Mentari Therapeutics develops targeted biological therapies for migraine treatment, focusing on PACAP pathway inhibition through monoclonal and bispecific antibodies for patients with inadequate relief from existing anti-CGRP therapies.
Investors · 1
Related companies · 3
Flagship PioneeringFlagship Pioneering is a firm that builds and funds companies in life sciences and related fields, describing itself as focused on breakthroughs for people and the planet.
Montara TherapeuticsMontara is a biotech company developing small-molecule therapeutics focused on neurodegeneration and diseases such as Alzheimer's. It was founded by scientists whose prior company, Mitokinin, was acquired by AbbVie in 2023.
Muna TherapeuticsMuna Therapeutics is a biotechnology company developing therapeutics, with a focus on drug discovery involving medicinal chemistry.
Companies working in the same space as Mentari Therapeutics.
In the news
Frequently asked questions
- What does Mentari Therapeutics do?
- Mentari Therapeutics develops targeted biological therapies for migraine treatment, focusing on PACAP pathway inhibition through monoclonal and bispecific antibodies for patients with inadequate relief from existing anti-CGRP therapies.
- Who are Mentari Therapeutics's investors?
- Mentari Therapeutics's investors include Andreessen Horowitz.